Enhanced medical implant comprising disrupted tooth pulp and tooth particles
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C12N-005/00
A01N-063/00
출원번호
US-0655633
(2010-01-04)
등록번호
US-8470308
(2013-06-25)
발명자
/ 주소
Wasielewski, Ray C.
출원인 / 주소
Wasielewski, Ray C.
대리인 / 주소
Wood, Herron & Evans, LLP
인용정보
피인용 횟수 :
2인용 특허 :
25
초록▼
A medical implant comprising in components from a tooth and stem cells harvested from at least one tooth. Tooth stem cells may be harvested from the dental pulp of mammalian teeth, such as unerupted third molars in humans. After the stem cells are removed and isolated from the other teeth tissue, th
A medical implant comprising in components from a tooth and stem cells harvested from at least one tooth. Tooth stem cells may be harvested from the dental pulp of mammalian teeth, such as unerupted third molars in humans. After the stem cells are removed and isolated from the other teeth tissue, the hard tooth may be ground into a base material for the manufacture of a porous matrix into which the tooth stem cells can be added. Additionally, soft tissue from the harvested tooth may be used as a carrier scaffold for soft tissue applications such as meniscal or cartilage repair.
대표청구항▼
1. A medical treatment composition comprising: physically disrupted, non-collagenase-digested tooth pulp including a plurality of stem cells; anda plurality of ground mammalian tooth particles. 2. The medical treatment composition of claim 1, wherein the plurality of ground mammalian tooth particles
1. A medical treatment composition comprising: physically disrupted, non-collagenase-digested tooth pulp including a plurality of stem cells; anda plurality of ground mammalian tooth particles. 2. The medical treatment composition of claim 1, wherein the plurality of ground mammalian tooth particles includes dentin, enamel, or mixtures thereof. 3. The medical treatment composition of claim 1, wherein the plurality of ground mammalian tooth particles includes particles of tooth derived hydroxyapatite. 4. The medical treatment composition of claim 1, wherein the plurality of ground mammalian tooth particles includes one or more endogenous or exogenous growth factors. 5. The medical treatment composition of claim 4, wherein the one or more endogenous or exogenous growth factors are chosen from transforming growth factor beta, insulin like growth factor I, insulin like growth factor II, platelet-derived growth factor, fibroblast growth factor, and bone morphogenetic proteins. 6. The medical treatment composition of claim 1, wherein the physically disrupted, non-collagenase-digested tooth pulp is selected from the group consisting of a diced tooth pulp, a minced tooth pulp, and combinations thereof. 7. The medical treatment composition of claim 1, wherein the physically disrupted, non-collagenase-digested tooth pulp is a sterilized, physically disrupted, non-collagenase digested tooth pulp, and wherein the sterilized, physically disrupted, non-collagenase digested tooth pulp includes a plurality of stem cells that are living. 8. The medical treatment composition of claim 1, wherein the plurality of stem cells includes pluripotent stem cells. 9. The medical treatment composition of claim 1, wherein the plurality of ground mammalian tooth particles have a mean particle size in the range of 5 μm to 100 μm. 10. The medical treatment composition of claim 1, wherein the plurality of ground mammalian tooth particles have a mean particle size in the range of 100 μm to 500 μm. 11. The medical treatment composition of claim 1, wherein the plurality of ground mammalian tooth particles have a mean particle size in the range of 500 μm to 1,000 μm.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (25)
Shi,Songtao; Gronthos,Stan; Robey,Pamela Gehron, Adult human dental pulp stem cells in vitro and in vivo.
Owen, Donald R.; Kravitz, David C.; Brassil, John; Brockbank, Kelvin G. M.; Burroughs, Andrew; Isaacs, Dickon; Steibel, Dennis; Fraser, Richard; Harris, Stanley; Schein, Douglas, Apparatus and method for maintaining and/or restoring viability of organs.
Hiatt Andrew C. ; Ma Julian K.-C.,GBX ; Lehner Thomas,GBX ; Mostov Keith E., Method for producing immunoglobulins containing protection proteins in plants and their use.
Brockbank,Kelvin G. M.; Campbell,Lia H.; Ratcliff,Kelly M.; Sarver,Kristy A., Method for treatment of cellular materials with sugars prior to preservation.
Yelick, Pamela C.; Bartlett, John D.; Vacanti, Joseph P.; Olsen, Bjorn R.; Stashenko, Phillip, Methods and compositions for culturing a biological tooth.
Carinci, Francesco; D'Aquino, Riccardo; De Rosa, Alfredo; Graziano, Antonio; Laino, Gregorio; Papaccio, Gianpaolo, Stem cells obtained from pulp of deciduous or permanent teeth and of dental germ, able to produce human bone tissue.
Reves, Benjamin T.; Scher, David S.; Drapeau, Susan J.; Harrington, Roger E.; Jacobs, Jerbrena C., Malleable implants including an oxysterol and methods of use.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.